Azur Pharma completes €40m private placement

Azur Pharma Limited today announced the successful completion of a private placement of €40m of equity securities.

The private placement was arranged through Davy Corporate Finance Limited.

Azur Pharma was founded in March 2005 with the mission of creating a US pharmaceutical business focused on developing and marketing products in specialist therapeutic areas.

Azur Pharma aim to build a portfolio of established pharmaceutical brands.

"Our experienced management team, significant financial resources and clear strategy provide a strong platform to execute our mission," said Mr Seamus Mulligan, Azur Pharma’s Chairman and Chief Executive Officer.